Adding Ribavirin to Newer DAA Regimens Does Not Affect SVR Rates in HCV Patients
Newer directly-acting antiviral agent (DAA) regimens offer high sustained virologic response (SVR) rates regardless of whether or not ribavirin is also prescribed, according to a study of veterans with Hepatitis C Virus (HCV) infection.